Cetera Advisor Networks LLC Can Fite Bio Pharma Ltd. Transaction History

Cetera Advisor Networks LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.94 - $1.45 $122,929 - $189,625	-130,776 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$1.65 - $2.34 $43,784 - $62,094	-26,536 Reduced 16.87%	130,776 $217,000
Q2 2021 Aug 13, 2021	SELL	$1.97 - $2.48 $5,295 - $6,666	-2,688 Reduced 1.68%	157,312 $359,000
Q1 2021 May 17, 2021	BUY	$1.8 - $2.92 $288,000 - $467,200	160,000 New	160,000 $395,000

1.1K

Ticker CANF
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,191,500
Market Cap $65.3M
Description
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.